Caliway Biopharmaceuticals (TWSE: 6919), a clinical-stage biopharmaceutical company developing novel small-molecule therapeutics, announced that preclinical research involving CBL-514 was presented at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback